Large population-based cohort studies like UK Biobank are crucial for drug discovery, providing the statistical power needed to identify small effects that would otherwise go unnoticed. Data assets can be generated in-house or accessed from external sources, each approach having its own advantages and challenges. Pharmaceutical research demands structured, quality data, with drug development being… Continue reading Building Data Assets in Drug Discovery
